Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups

    NEXT STORY
    Psyence Group Inc Completes Reverse Takeover Transaction and Completes Non-brokered Financing
    PREV STORY
    PM360 Adds Two New Categories for 2021 Trailblazer Awards
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Immunoassay Markets Strategies, Trends & Forecasts 2019-2023: Multiplex And Point Of Care Market Analysis, Executive Guides And Including Customized Forecasting

    author_avatar
    NASDAQ Market News

    Adicet Appoints Don Healey, Ph.D., as Chief Technology Officer

    author_avatar
    NASDAQ Market News

    The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing

    THE WOODLANDS, Texas and SALT LAKE CITY, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Myriad ...

    author_avatar
    NASDAQ Market News